A detailed history of Encompass Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Encompass Wealth Advisors, LLC holds 7,620 shares of AMGN stock, worth $2.41 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
7,620
Previous 5,118 48.89%
Holding current value
$2.41 Million
Previous $1.46 Million 63.57%
% of portfolio
0.9%
Previous 0.53%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $657,400 - $798,913
2,502 Added 48.89%
7,620 $2.38 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $246,822 - $297,946
-918 Reduced 15.21%
5,118 $1.46 Million
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $2,301 - $2,596
-9 Reduced 0.15%
6,036 $1.74 Million
Q3 2023

Nov 07, 2023

SELL
$218.65 - $271.46 $91,395 - $113,470
-418 Reduced 6.47%
6,045 $1.62 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $2,142 - $2,533
-10 Reduced 0.15%
6,463 $1.43 Million
Q1 2023

May 04, 2023

BUY
$225.79 - $275.2 $37,255 - $45,408
165 Added 2.62%
6,473 $1.56 Million
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $11,451 - $14,550
-50 Reduced 0.79%
6,308 $1.66 Million
Q3 2022

Oct 28, 2022

SELL
$224.46 - $253.15 $35,015 - $39,491
-156 Reduced 2.39%
6,358 $1.43 Million
Q2 2022

Aug 03, 2022

SELL
$230.71 - $256.74 $10,151 - $11,296
-44 Reduced 0.67%
6,514 $1.59 Million
Q4 2021

Jan 20, 2022

BUY
$198.88 - $227.6 $596 - $682
3 Added 0.05%
6,558 $1.48 Million
Q3 2021

Nov 16, 2021

SELL
$212.27 - $248.7 $847,594 - $993,059
-3,993 Reduced 37.86%
6,555 $1.39 Million
Q1 2021

May 25, 2021

BUY
$221.91 - $258.6 $2.28 Million - $2.66 Million
10,292 Added 4020.31%
10,548 $2.61 Million
Q4 2020

Mar 09, 2021

SELL
$216.38 - $257.67 $2.22 Million - $2.64 Million
-10,248 Reduced 97.56%
256 $59,000
Q4 2020

Mar 09, 2021

BUY
$216.38 - $257.67 $2.27 Million - $2.71 Million
10,504 New
10,504 $2.42 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Encompass Wealth Advisors, LLC Portfolio

Follow Encompass Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Encompass Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Encompass Wealth Advisors, LLC with notifications on news.